B O O K - American College of Rheumatology

ACR Poster Session A
168
308. Durability of Clinical Remission in Rheumatoid Arthritis
Based on Various Criteria. Femke H. M. Prince 2 , Vivian P.
Bykerk 2 , Nancy A. Shadick 1 , Jing Cui 2 , Michele Frits 2 , Christine
K. Iannaccone 2 , Michael E. Weinblatt 3 and Daniel Hal Solomon 3 ,
1
Brigham & Womens Hospital, Boston, MA, 2 Brigham and
Women’s Hospital, Division of Rheumatology, Immunology and
Allergy, BRASS, Boston, MA, 3 Brigham and Womens Hospital,
Boston, MA.
309. Effect of Anti-Tumor Necrosis Factor Alpha Therapy on
Cardiovascular Events in Rheumatoid Arthritis: A Systematic
Review and Meta-Analysis. Cheryl C. M. Barnabe 2 , Billie-Jean
Martin 1 and William A. Ghali 2 , 1 Libin Cardiovascular Institute,
2
University of Calgary, Calgary, AB, Canada.
310. Effect of Intensive Repletion and Maintenance Vitamin D
Therapy in Rheumatoid Arthritis Patients. Uzma J. Haque 1 ,
Kevin Fontaine 2 and Susan J. Bartlett 3 , 1 Johns Hopkins School of
Medicine, Lutherville, MD, 2 Johns Hopkins School of Medicine,
3
McGill University, Montreal, QC, Canada.
311. Effectiveness of Initial Treatment Allocation Based on Expert
Opinion for Prevention of Rapid Radiological Progression
in a Daily Practice Early RA Cohort. Anne Durnez 2 , Geert
Vanderschueren 1 , Luc Lateur 1 , Rene Westhovens 2 and Patrick
Verschueren 2 , 1 University Hospital Leuven Radiology, Leuven,
Belgium, 2 University Hospital Leuven Rheumatology, Leuven,
Belgium.
312. ESR, CRP, or RF Status at Presentation Is Only Marginally
Predictive of Future Treatments with Methotrexate or Biologic
Agents over 25 Years in Two Settings in the United States and
in Finland. Tuulikki Sokka 1 , Hannu Kautiainen 2 and Theodore
Pincus 3 , 1 Jyvaskyla Central Hospital, Jyvaskyla, Finland, 2 Medcare
Oy, Annekoski, Finland, 3 New York University Hospital for Joint
Disease, Hastings-on-Hudson, NY.
313. Invasive Fungal Infections in Seniors with Rheumatoid
Arthritis: A Population-Based Study from the Ontario Biologics
Research Initiative. Jessica Widdifield 7 , Sasha R. Bernatsky 3 ,
J. Michael Paterson 1 , Nadia Gunraj 2 , Janet E. Pope 6 , J. Carter
Thorne 5 , Alfred A. Cividino 4 and Claire Bombardier 7 , 1 Institute
for Clinical Evaluative Science, Canada, 2 Institute for Clinical
Evaluative Science, 3 McGill UHC/RVH, Montreal, QC, Canada,
4
McMaster University, Hamilton, ON, Canada, 5 Southlake
Regional Health Care, Newmarket, ON, Canada, 6 St Joseph
Health Care London, London, ON, Canada, 7 University of
Toronto.
314. Is DAS28 Remission Good Enough? Disease Activity and
Functionality in Rheumatoid Arthritis, Results of the DREAM
Remission Induction Cohort. Marloes Vermeer 3 , Ina H. Kuper 3 ,
Monique Hoekstra 1 , Hein J. Bernelot Moens 4 , Piet L. C. M. van
Riel 2 and Mart A. F. J. van de Laar 3 , 1 Isala Klinieken, Zwolle,
The Netherlands, 2 Radboud University Nijmegen Medical
Centre, Nijmegen, The Netherlands, 3 University of Twente
and Medisch Spectrum Twente, Enschede, The Netherlands,
4
Ziekenhuisgroep Twente, Almelo/Hengelo, The Netherlands.
315. Low Rate of Rheumatoid Arthritis Remission in Real Life: Might
Predictive Factors Explain? Elodie Loppin 2 , Ronan Garlantezec 1
and Elisabeth Solau-Gervais 2 , 1 Public Heatlh Department,
University Hospital Brest, France, 2 Rheumatology Department
University Hospital Poitiers, France.
316. Lymphocytopenia and Infection Risk in Rheumatoid Arthritis:
A Population Based Analysis. Deana D. Hoganson 2 , Eric L.
Matteson 1 , Patrick D. Fitz-Gibbon 3 and Cynthia S. Crowson 3 ,
1
Mayo Clinic, Rochester, MN, 2 Mayo Clinic Rochester, Rochester,
MN, 3 Mayo Clinic Rochester.
2010 Program Book
317. Measures of Disease Activity Provide Various Clinical Decisions
in Individual Patients. P. H. P. de Jong 1 , J. M. W. Hazes 2 , J. J.
Luime 2 and A. E. A. M. Weel 3 , 1 Department of Rheumatology,
ErasmusMC, Rotterdam, The Netherlands, 2 Department of
Rheumatology, ErasmusMC, Rotterdam, 3 Department of
Rheumatology, Maasstad Hospital, Rotterdam.
318. Minocycline and Doxycycline Therapy in Community Patients
with Rheumatoid Arthritis (RA): Incidence, Patient-Level
Determinants of Use and Side Effects. Christopher J. Smith 2 ,
Harlan R. Sayles 2 , Ted R. Mikuls 1 and Kaleb D. Michaud 1 , 1 Univ of
Nebraska Med Ctr, Omaha, NE, 2 University of Nebraska Med Ctr,
Omaha, NE.
319. Multi-Centre, Cross-Sectional, Observational Study of the
Safety of Methotrexate and Leflunomide in Combination in
the Treatment of Patients with Rheumatoid Arthritis The
SMILE Study – Safety of Methotrexate In Combination with
Leflunomide. Paul Bird 2 , Hedley Griffiths 1 and The Optimising
Patient Outcomes in Australian RheumatoLogy [OPAL]
Consortium, 1 Barwon Rheumatology Service, Victoria, Australia,
2
Combined Rheumatology Practice (CRP), University of NSW,
Sydney, NSW, Australia.
320. Multi-Centre, Observational Study Shows High Proportion of
Australian Rheumatoid Arthritis Patients Have Inadequate
Disease Control. Geoffrey Littlejohn 2 and Kathleen E. Tymms 1 ,
1
Canberra Rheumatology, Canberra, ACT, Australia, 2 Monash
Medical Centre, Clayton, Victoria, Australia.
321. Multiple Courses of Rituximab Produce Sustained Efficacy
in Patients with Rheumatoid Arthritis with an Inadequate
Response to One or More TNF Inhibitors. Edward C. Keystone 6 ,
Roy M. Fleischmann 5 , Paul Emery 2 , Maxime Dougados 3 , Sarah
Williams 4 , Matthew D. Linnik 1 and Mark Reynard 4 , 1 Biogen
Idec, San Diego, San Diego, CA, 2 Chapel Allerton Hospital,
Leeds, United Kingdom, 3 Hospital Cochin, Paris, France, 4 Roche
Products Ltd, Welwyn Garden City, UK, 5 University of Texas
Southwestern Medical Center, Dallas, Dallas, TX, 6 University of
Toronto, Toronto, ON, Canada.
322. National Trends in Drug Use, Health Status and Costs in Older
Americans with Rheumatoid Arthritis. Leslie R. Harrold 3 , Becky
Briesacher 4 , Daniel Peterson 1 and Jerry H. Gurwitz 2 , 1 Meyers
Primary Care Institute, 2 Meyers Primary Care Institute/UMass
Medical School, 3 UMass Medical Schl, Worcester, MA, 4 UMass
Medical School.
323. Pandemic H1N1 Influenza Vaccination Responses in Rheumatid
Arthritis and Systemic Lupus Erythematosus Patients: An
Association with Serum IL17 and CXCL13 Level. Sung-Hoon
Park 1 , Hwa-Jeong Lee 2 , Hyun-Hee Kwon 2 , Seong-Kyu Kim 2 and
Jung-Yoon Choe 2 , 1 Catholic University of Daegu, School of
Medicine, Arthritis and Autoimmunity Research Center, Daegu,
Korea, Republic of, 2 Catholic University of Daegu, School of
Medicine, Arthritis and Autoimmunity Research Center.
324. Patient Preferences for Biologic Agents in Rheumatoid
Arthritis: A Discrete Choice Experiment. David A. Navarta 2 ,
Federico Augustovski 3 , Andrea Beratarrechea 3 , Vilma Irazola 3 ,
Fernando Rubinstein 3 , Pablo Tesolin 3 , Juan M. Gonzalez 6 ,
Veronica Lencina 4 , Marina Scolnik 2 , Christian Wainmann 5 ,
Gustavo Citera 4 and Enrique R. Soriano 1 , 1 Hospital Italiano
de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires,
Capital Federal, Argentina, 2 Hospital Italiano de Buenos
Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina,
Argentina, 3 Institute for Clinical Effectiveness and Health Policy,
Buenos Aires, Argentina, 4 Instituto Rehabilitacion Psicofisica,
Buenos Aires, Argentina, 5 Instituto Rehabilitacion Psicofisica,
Buenos Aires, Argentina, 6 RTI Health Solutions, NC.